Rituxan better than Fingolimod, Dymethyl fumarate and Natalizumab

1 post • Page 1 of 1

frodo: Family Elder; Posts: 1523; Joined: Wed Dec 02, 2009 3:00 pm; Contact:
Contact frodo

ICQ

Rituxan better than Fingolimod, Dymethyl fumarate and Natalizumab

Quote

Post by frodo » Tue Aug 11, 2020 2:03 am

Rituxan better than Fingolimod, Dymethyl fumarate and Natalizumab

https://onlinelibrary.wiley.com/doi/ful ... acn3.51111

Interpretation

RTX demonstrated superior effectiveness and discontinuation outcomes compared to FTY and DMF. Although RTX demonstrated similar effectiveness and discontinuation compared to NTZ, RTX had superior effectiveness during months 6–24 and fewer discontinuations when excluding discontinuations due to insurance issues. Results suggest superiority of RTX in reducing disease activity and maintaining long‐term treatment in a real‐world MS cohort.

Post Reply

1 post • Page 1 of 1

Similar Topics

Replies

Views

Last post

Diroximel fumarate phase III study

Last post by NHE « Wed Jul 01, 2020 6:18 am
Posted in Vumerity (diroximel fumarate)

by NHE » Wed Jul 01, 2020 6:18 am » in Vumerity (diroximel fumarate)

Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared With Dimethyl Fumarate in Patients With...

0 Replies

278 Views

Last post by NHE
Wed Jul 01, 2020 6:18 am
RE: CLEMASTINE FUMARATE RESTORES MYELIN IN M.S

Last post by frodo « Mon Mar 18, 2019 10:13 am
Posted in General Discussion
Replies: 4
by seeva » Thu Feb 28, 2019 7:21 pm » in General Discussion

First post

HI FRIENDS

FDA approved antihistamine restores nervous system function in patient with chronic M.S
regards
seeva

Last post

CLEMASTINE FUMARATE RESTORES MYELIN IN M.S

It is really not important. Myelin is just the tip of the iceberg. The important therapy would be one...

4 Replies

757 Views

Last post by frodo
Mon Mar 18, 2019 10:13 am
Dimethyl fumarate associates with CD8+ cells reduction

Last post by frodo « Thu Dec 19, 2019 5:21 am
Posted in MS Etiology and Pathogenesis

by frodo » Thu Dec 19, 2019 5:21 am » in MS Etiology and Pathogenesis

IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis

Abstract

IL-17-producing CD8+...

0 Replies

429 Views

Last post by frodo
Thu Dec 19, 2019 5:21 am
Fingolimod better than interferon beta and GA

Last post by frodo « Tue Jun 02, 2020 12:34 am
Posted in General Discussion

by frodo » Tue Jun 02, 2020 12:34 am » in General Discussion

Disability progression in relapse-free multiple sclerosis patients on fingolimod versus interferon-beta/glatiramer acetate

Abstract...

0 Replies

196 Views

Last post by frodo
Tue Jun 02, 2020 12:34 am
FDA approves generic fingolimod

Last post by NHE « Tue Jun 30, 2020 8:35 am
Posted in Gilenya

by NHE » Tue Jun 30, 2020 8:35 am » in Gilenya

FDA Approves Generic Versions of Gilenya
December 6, 2019

On December 5, 2019, the United States Food and Drug Administration (FDA) announced...

0 Replies

266 Views

Last post by NHE
Tue Jun 30, 2020 8:35 am
Personalized medicine: Prediction of natalizumab response

Last post by frodo « Tue May 28, 2019 6:29 am
Posted in MS Etiology and Pathogenesis

by frodo » Tue May 28, 2019 6:29 am » in MS Etiology and Pathogenesis

Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing‑remitting multiple sclerosis to natalizumab...

0 Replies

640 Views

Last post by frodo
Tue May 28, 2019 6:29 am
T-cell analysis predicts response to Natalizumab

Last post by frodo « Thu Sep 05, 2019 6:39 am
Posted in MS Etiology and Pathogenesis

by frodo » Thu Sep 05, 2019 6:39 am » in MS Etiology and Pathogenesis

Abstract.

Multiple sclerosis (MS) is a chronic inflamma-tory disease of the central nervous system of autoimmune etiopathogenesis, and is...

0 Replies

628 Views

Last post by frodo
Thu Sep 05, 2019 6:39 am
Incidence of fingolimod-associated macular oedema

Last post by NHE « Sun May 17, 2020 7:58 pm
Posted in Gilenya
Replies: 1
by NHE » Sat May 16, 2020 9:25 am » in Gilenya

First post

Real-world incidence of fingolimod-associated macular oedema.
Mult Scler Relat Disord. 2020 Apr 28;42:102125.

BACKGROUND: Fingolimod (Gilenya,...

Last post

Real-world incidence of fingolimod-associated macular oedema.
Mult Scler Relat Disord. 2020 Apr 28;42:102125.

I was initially unaware of the...

1 Replies

228 Views

Last post by NHE
Sun May 17, 2020 7:58 pm
Safety and efficacy of ozanimod vs. fingolimod

Last post by NHE « Sat Apr 25, 2020 2:33 am
Posted in Zeposia (Ozanimod)

by NHE » Sat Apr 25, 2020 2:33 am » in Zeposia (Ozanimod)

Comparative safety and efficacy of ozanimod versus fingolimod for relapsing multiple sclerosis.
J Comp Eff Res. 2020 Mar;9(4):275-285.

Aim:...

0 Replies

139 Views

Last post by NHE
Sat Apr 25, 2020 2:33 am

Return to “MS Etiology and Pathogenesis”